MedicaidAdministrativeLow impact

Newsletter Vol. 21, No.23

Q: Who is affected by this change?

This affects New Jersey Medicaid Pain Management, Family Medicine, Internal Medicine, General Practice, Orthopedics, Neurology +2 more providers in NJ on Medicaid plans.

New Jersey Medicaid·NJ · Pain Management, Family Medicine, Internal Medicine +5 more·Prior Authorization

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

New Jersey Drug Utilization Review Board issued clinical guidelines for safe prescribing of oxycodone controlled-release formulations, including treatment protocols, abuse prevention measures, and equianalgesic dosing recommendations. This is educational guidance for providers rather than a billing policy change.

Action Required

Action needed

Providers should review the clinical guidelines for oxycodone CR prescribing, including the VIGIL abuse prevention protocol and equianalgesic dosing tables. Consider implementing documentation practices that support appropriate opioid prescribing for chronic pain management.

Related policy hubs

New Jersey Medicaid policies NJ policy changes Pain Management Family Medicine Internal Medicine General Practice Orthopedics Neurology Oncology Palliative Care